
Opinion|Videos|September 17, 2025
Rapid Therapeutic Effects Seen With a JAK Inhibitor
Key Takeaways
- Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles.
- Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells.
Panelists discuss how the Bayesian network meta-analysis showed which Janus kinase (JAK) inhibitors were most effective in reducing Severity of Alopecia Tool (SALT) scores in alopecia areata (AA), highlighting which therapies achieved 50% and 75% improvement, and whether SALT scores are an effective measure of treatment success.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Ungar: The Severity of Alopecia Tool (SALT) is a validated tool utilized to assess the clinical severity of alopecia with scores ranging from 0 (no scalp hair loss) to 100 (complete scalp hair loss). In the Bayesian network
meta-analysis, which JAK inhibitor(s) demonstrated the best relative effect in reducing SALT scores pre and post intervention?- Which JAK inhibitor(s) demonstrated patients achieving 50% improvement?
- Which JAK inhibitor(s) demonstrated patients achieving 75% improvement?
- Do you believe this is an effective way to evaluate the effectiveness of an AA intervention?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Student Mental Health, Success Tied to Future Health and Affordability
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Mobile Integrated Health Valuable in Heart Failure, but Payment Lags
5



